ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

OPK Opko Health Inc

1,315
0,015 (1,15%)
Zuletzt aktualisiert: 20:13:07
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Opko Health Inc OPK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,015 1,15% 1,315 20:13:07
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,29 1,29 1,32 1,30
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202414:00GLOBEOPKO Health to Report First Quarter 2024 Financial Results..
28.3.202413:00PRNUSLabcorp Announces Acquisition of Select Assets of..
20.3.202413:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
07.3.202422:02EDGAR2Form ARS - Annual Report to Security Holders
05.3.202414:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
01.3.202422:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28.2.202415:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
27.2.202422:07EDGAR2Form 8-K - Current report
27.2.202422:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
22.2.202422:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
16.2.202422:53EDGAR2Form PRE 14A - Other preliminary proxy statements
09.2.202422:07EDGAR2Form 8-K - Current report
05.2.202414:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
29.1.202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
24.1.202422:00EDGAR2Form 8-K - Current report
17.1.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202423:09EDGAR2Form 8-K - Current report
09.1.202422:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
08.1.202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202414:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
05.1.202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202413:00EDGAR2Form 8-K - Current report
05.1.202405:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
03.1.202423:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
28.11.202313:00PRNUSBioReference Health and Prognos Health Collaborate to..
13.11.202314:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202312:45PRNUSBioReference® Signs On as the First Laboratory to Use..
06.11.202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:06EDGAR2Form 8-K - Current report
06.11.202322:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
02.11.202315:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
31.10.202321:08EDGAR2Form 8-K/A - Current report: [Amend]
31.10.202313:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
25.10.202322:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
28.9.202323:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
28.9.202322:09EDGAR2Form 8-K - Current report
28.9.202322:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
12.9.202314:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
03.8.202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:07EDGAR2Form 8-K - Current report
03.8.202322:05GLOBEOPKO Health Reports Second Quarter 2023 Business Highlights..
25.7.202322:05GLOBEOPKO Health to Report Second Quarter 2023 Financial Results..
30.6.202322:10EDGAR2Form 8-K - Current report
28.6.202312:45BWFDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock